← 返回专利悬崖列表
CAS 1239729-06-6
6-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one
登记编号：RP-5063-008
应用背景（按来源药适应症）
精神分裂症Brilaroxazine重度抑郁症Brilaroxazine肺动脉高压Brilaroxazine特发性肺纤维化Brilaroxazine躁狂症Brilaroxazine注意力缺陷障碍伴多动Brilaroxazine
来源药（使用该中间体的合成路线）
| 品种 | 梯队 | 到期年 |
|---|---|---|
| Brilaroxazine | Tier C · 观察 / 贸易 | - |
合成路线中的位置（上下游链）
按路线登记顺序排列，左→右为合成方向；高亮为当前 CAS，其余可点击跳转对应档案。
RP-5063→4-methoxy-2-nitrophenol→ethyl 2-(4-methoxy-2-nitrophenoxy)acetate→ethyl 2-(4-hydroxy-2-nitrophenoxy)acetate→1,4-dibromobutane→ethyl 2-(4-(4-bromobutoxy)-2-nitrophenoxy)acetate→1-(2,3-dichlorophenyl)piperazine hydrochloride→ethyl 2-(4-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-nitrophenoxy)acetate→6-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one
本站可供应的对应中间体
同 CAS 多家在售供应横向对比；价格区间为供应方挂牌口径，实价以询价确认为准。
| 供应商 | 产品 | 价格区间 | 最小起订 | 货期 | 资质 | 操作 |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 1-(2,3-Dichlorophenyl)piperazine hydrochloride Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — | |
| Unibest Nantong cGMP Site | ethyl 2-(4-(4-(4-(2,3-dichlorophenyl)pipe Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — | |
| Unibest Taizhou GMP-like Site | ethyl 2-(4-(4-bromobutoxy)-2-nitrophenoxy)acetate Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — | |
| Qualified Partner — East China API Works | 3,3-dimethyldihydro-2H-pyran-2,6(3H)-dione Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — | |
| Unibest Nantong cGMP Site | methyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — | |
| Unibest Taizhou GMP-like Site | (S)-3-(5-bromo-1-ethyl-2-(2-(1-methoxyethyl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropan-1-ol Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
本页为中间体 CAS 注册档案：同 CAS 的多条路线登记已合并；后续供应商报价与买方需求以该 CAS 为主键撮合。